0.9%-2.7%), for EHIT II toe IV 1.4 % (0.8%-2.3%), for DVT
0.3% (0.2%-0.5%), and for PE 0.1% (0.1%-0.02%). Signiﬁcant heterogeneity was noted for EHIT II to IV þ PE and
EHIT II to IV, but not for DVT or PE.

A third systematic review including